MedTrace Logo

AvertD Post-Approval Study

NCT07135323 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2025-08-22

No results posted yet for this study

Summary

A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population

Conditions

Interventions

GENETIC

Opioid Used Disorder Risk Assessment

Determine the likelihood of Opioid Used Disorder prior to prescribing opioids

Sponsors & Collaborators

  • Caron Treatment Centers

    collaborator OTHER

  • Concentrics Research

    collaborator OTHER

  • Prescient Medicine Holdings, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-15
Primary Completion
2031-11-30
Completion
2031-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07135323 on ClinicalTrials.gov